 |
|
FDA ignores critical information on home HIV tests
May 29, 2009The FDA is ignoring critical information in deciding whether to approve an over-the-counter, rapid HIV test for home use, according to a recent article in the journal Medical Decision Making (MDM) which is published by SAGE.
As the price of the HIV test rises, some lower-income individuals who are at greater risk for HIV infection will not be able to afford it. The FDA has been criticized because it bases its decisions on small studies performed in non-representative populations.
"When approving new technologies, the FDA should focus less on the general population and more on the people who will actually use these technologies," said co-author A. David Paltiel, PhD, of the Yale School of Medicine. "The disconnect between approved indication and actual use is stark."
The test in question is the OraQuick ADVANCE 1/2, a rapid, point-of-care test that can detect antibodies to both HIV-1 and HIV-2 in 20 minutes using a simple cheek swab. The test is already FDA-approved for use in health care settings such as hospitals, drug treatment facilities, state and local health departments, clinics, community-based organizations, and university health centers throughout the United States.
The FDA has asked the manufacturer to collect data on the ability of the test to correctly detect both the presence and absence of HIV infection when employed by untrained users. However, it has not requested any further information on how the manufacturer's retail price will influence the demand for home testing in populations with high-rates of undetected HIV infection. Using a mathematical analysis, the authors demonstrate that many of the highest-risk individuals will be unable to afford home testing at the price the manufacturer is likely to propose. By failing to take into account the relationship between retail pricing, consumer purchasing behavior, and HIV risk, the FDA may overestimate the test's ability to identify previously undetected cases of HIV infection.
"The information currently sought by the FDA is not sufficient to address the true benefit of the HIV test for home use," write Paltiel and co-author Harold A. Pollack, PhD of the University of Chicago School of Social Service Administration. "Our analysis suggests that a cheaper test may do a better job of finding HIV infection. The home HIV test product might actually work better at a lower price."
SAGE Publications
The test in question is the OraQuick ADVANCE 1/2, a rapid, point-of-care test that can detect antibodies to both HIV-1 and HIV-2 in 20 minutes using a simple cheek swab. The test is already FDA-approved for use in health care settings such as hospitals, drug treatment facilities, state and local health departments, clinics, community-based organizations, and university health centers throughout the United States.
The FDA has asked the manufacturer to collect data on the ability of the test to correctly detect both the presence and absence of HIV infection when employed by untrained users. However, it has not requested any further information on how the manufacturer's retail price will influence the demand for home testing in populations with high-rates of undetected HIV infection. Using a mathematical analysis, the authors demonstrate that many of the highest-risk individuals will be unable to afford home testing at the price the manufacturer is likely to propose. By failing to take into account the relationship between retail pricing, consumer purchasing behavior, and HIV risk, the FDA may overestimate the test's ability to identify previously undetected cases of HIV infection.
"The information currently sought by the FDA is not sufficient to address the true benefit of the HIV test for home use," write Paltiel and co-author Harold A. Pollack, PhD of the University of Chicago School of Social Service Administration. "Our analysis suggests that a cheaper test may do a better job of finding HIV infection. The home HIV test product might actually work better at a lower price."
SAGE Publications
HIV Current Events and HIV News RSSNew Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer
Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.
Magnetic nanoparticles to simultaneously diagnose, monitor and treat
Whether it's magnetic nanoparticles (mNPs) giving an army of 'therapeutically armed' white blood cells direction to invade a deadly tumour's territory, or the use of mNPs to target specific nerve channels and induce nerve-led behaviour (such as the life-dependant thumping of our hearts), mNPs have come a long way in the past decade.
Global challenges and opportunities in fighting HIV/AIDS and neglected diseases
Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs.
Hepatitis B does not increase risk for pancreatic cancer
A Henry Ford Hospital study found that hepatitis B does not increase the risk for pancreatic cancer - and that only age is a contributing factor.
Cell phones become handheld tools for global development
Mobile phones are on the verge of becoming powerful tools to collect data on many issues, ranging from global health to the environment.
Scientists use world's fastest supercomputer to create the largest HIV evolutionary tree
Supporting Los Alamos National Laboratory's role in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, researchers are using the Roadrunner supercomputer to analyze vast quantities of genetic sequences from HIV infected people in the hope of zeroing in on possible vaccine target areas.
Will genomics help prevent the next pandemic?
This week, the Public Library of Science, an open-access publisher, presents the "Genomics of Emerging Infectious Disease," a collection of essays, perspectives, and reviews that explores how genomics-with all its associated tools and techniques-can provide insights into our understanding of emerging infectious disease.
Science at the Petascale: Roadrunner Results Unveiled
The world's fastest supercomputer, Roadrunner, at Los Alamos National Laboratory has completed its initial "shakedown" phase doing accelerated petascale computer modeling and simulations of a variety of unclassified, fundamental science projects.
M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers
Drawing on years of experience in cancer research and patient care, The University of Texas M. D. Anderson Cancer Center released today the most comprehensive, risk-based screening guidelines publicly available to date for breast, cervical and colorectal cancers.
Sperm may play leading role in spreading HIV
Sperm, and not just the fluid it bathes in, can transmit HIV to macrophages, T cells, and dendritic cells (DCs), report a team led by Ana Ceballos at the University of Buenos Aires in Argentina.
More HIV Current Events and HIV News Articles
 |
The First Year: HIV: An Essential Guide for the Newly Diagnosed (First Year, The) by Brett Grodeck (Author), M.D. Daniel S. Berger (Foreword) This supportive resource explores the next generation of HIV/AIDS drugs and also includes new research on HIV and crystal meth, as well as new insights for the hardest hit population — African Americans. |
 |
Home Access HIV - 1 Express Test System - 1 ea by Home Access Next Day Results* Contains one single-use sample collection kit |
 |
100 Questions and Answers About HIV and AIDS by Joel Gallant (Author) |
 |
Absolutely Positive Directed By: Peter Adair Also With: Janet Cole (Cinematographer), Peter Adair (Cinematographer), Peter Adair (Writer) Ten years following its ground-breaking debut at Sundance, the landmark film that first humanized the face of AIDS is now available in this special 10th Anniversary Edition. Simultaneously heart-wrenching and life affirming, ABSOLUTELY POSITIVE is an hon |
 |
HIV Essentials 2010 by Paul E. Sax (Author), Calvin J. Cohen (Author), Daniel R. Kuritzkes (Author) HIV Essentials 2010 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management and prevention of HIV infection and its complications. Topics include: HIV diagnosis, evaluation, treatment and prevention; Opportunistic infections and other HIV Complications; Treatment of HIV and pregnancy; Antiretroviral drug summaries; Post-exposure Prophylaxis; New section to each drug summary called "How Supplied" describes the commercially available dosage forms for all the ARV's |
 |
Home Access HIV - 1 Test System - 1 ea by Home Access Please note: Due to packaging updates, the image shown may temporarily appear different |
 |
Living with HIV: A Patient's Guide by Mark Cichocki (Author) This helpful guide offers a wealth of information for individuals who have been diagnosed with HIV and for people caring for HIV positive friends and loved ones. It covers the entire HIV lifespan, from prevention to diagnosis and beyond. Valuable tips help the reader make the best decision when choosing a doctor, finding and adhering to the right medication regimen, and, if necessary, making end-of-life plans. All aspects of HIV/AIDS are discussed, including opportunistic and associated infections, dental care, exercise and nutrition, substance use and abuse, and emotional treatment. |
 |
HIV and the Pathogenesis of AIDS, 3rd Edition by Jay A. Levy (Author) The new edition of HIV and the Pathogenesis of AIDS provides a state-of-the-art review of the current research, explains the history of the disease, and examines how scientists, clinicians, and public health workers have responded to the challenges presented by HIV/AIDS in the 25 years since its recognition. Many exciting developments in the field have deepened scientific understanding of HIV/AIDS and have provided novel approaches for prevention and treatment. The book explores potential approaches for therapy and a vaccine for the prevention of HIV infection and AIDS is discussed. Thoroughly updated and revised, the third edition continues to provide a comprehensive analysis of the subject that is unmatched in the field. Figures and tables illustrate and emphasize key points and... |
 |
Life Support Starring: Queen Latifah, Anna Deavere Smith, Wendell Pierce, Rachel Nicks, Evan Ross (III) Directed By: Nelson George HBO Films presents Academy Award® nominee Queen Latifah (Chicago) in a heartbreaking story of one woman's journey to the brink of self-destruction and despair, and her inspirational fight to gain back her dignity and her family. Ana is an HIV-positive former drug addict from Brooklyn, desperately struggling with her past and passionately trying to make things right with her involvement in an AIDS outreach group, Life Support. Inspired by a true story, Life Support is a touching, poignant tale of loving, losing and letting go. DVD Features: |
 |
The Naked Truth: Young, Beautiful, and (HIV) Positive by Marvelyn Brown (Author), Courtney Martin (Author) The surprisingly hopeful story of how a straight, nonpromiscuous, everyday girl contracted HIV and how she manages to stay upbeat, inspired, and more positive about life than ever before At nineteen years of age, Marvelyn Brown was lying in a stark white hospital bed at Tennessee Christian Medical Center, feeling hopeless. A former top track and basketball athlete, she was in the best shape of her life, but she was battling a sudden illness in the intensive care unit. Doctors had no idea what was going on. It never occurred to Brown that she might be HIV positive. Having unprotected sex with her Prince Charming had set into swift motion a set of circumstances that not only landed her in the fight of her life, but also alienated her from her community. Rather than give... |
| © 2009 BrightSurf.com |